Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression

被引:103
作者
Sun, Qingmin [1 ]
Cong, Rihong [1 ]
Yan, Hongli [2 ]
Gu, Haijuan [1 ]
Zeng, Ying [1 ]
Liu, Nannan [1 ]
Chen, Jie [1 ]
Wang, Bin [1 ]
机构
[1] Nanjing Med Univ, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China
[2] Dongzhi Hlth Inspect Bur, Dongzhi 247200, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
genistein; uveal melanoma; microRNA-27a; zinc finger and BTB domain containing 10; HUMAN BREAST-CARCINOMA; UP-REGULATION; PROSTATE-CANCER; HYPOXIA; SP1; METASTASIS; SURVIVAL; MIR-451; SOY;
D O I
10.3892/or_00000472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genistein, an isoflavone isolated from soybean, has been found to be a potent antitumor agent. However, both the effect of genistein on human uveal melanoma cells and the precise mechanism by which genistein suppresses tumorigenesis remain unclear. In the present study, we explored the possible activity of genistein to inhibit human uveal melanoma cell growth and investigated the possible role of genistein on microRNA-27a (miR-27a) as well as its target gene zinc finger and BTB domain containing 10 (ZBTB10) expression levels. The results suggested a significant inhibition of uveal melanoma cell growth in a time- and dose-related manner. In vivo study also indicated treatment groups with genistein could significantly inhibit the growth of xenografts. Further functional assays revealed that the levels of miR-27a and its target gene ZBTB10 were significantly different based on the dose of genistein. In conclusion, the present study demonstrates that genistein exerts growth inhibitory activities in human uveal melanoma cells. Moreover, we for the first time report a correlation between antitumor activity of genistein and miR-27a mediated regulatory mechanism.
引用
收藏
页码:563 / 567
页数:5
相关论文
共 36 条
[1]   Multi-targeted therapy of cancer by genistein [J].
Banerjee, Sanjeev ;
Li, Yiwei ;
Wang, Zhiwei ;
Sarkar, Fazlul H. .
CANCER LETTERS, 2008, 269 (02) :226-242
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   MicroRNAs modulate hematopoietic lineage differentiation [J].
Chen, CZ ;
Li, L ;
Lodish, HF ;
Bartel, DP .
SCIENCE, 2004, 303 (5654) :83-86
[4]   A REVIEW OF MORTALITY FROM CHOROIDAL MELANOMA .2. A METAANALYSIS OF 5-YEAR MORTALITY-RATES FOLLOWING ENUCLEATION, 1966 THROUGH 1988 [J].
DIENERWEST, M ;
HAWKINS, BS ;
MARKOWITZ, JA ;
SCHACHAT, AP .
ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (02) :245-250
[5]   Genistein [J].
Dixon, RA ;
Ferreira, D .
PHYTOCHEMISTRY, 2002, 60 (03) :205-211
[6]  
Farina HG, 2006, ONCOL REP, V16, P885
[7]   Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells [J].
Fujita, Yasunori ;
Kojima, Keitaro ;
Hamada, Nanako ;
Ohhashi, Riyako ;
Akao, Yukihiro ;
Nozawa, Yoshinori ;
Deguchi, Takashi ;
Ito, Masafumi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (01) :114-119
[8]   MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells [J].
Gal, Hilah ;
Pandi, Gopal ;
Kanner, Andrew A. ;
Ram, Zvi ;
Lithwick-Yanai, Gila ;
Amariglio, Ninette ;
Rechavi, Gideon ;
Givol, David .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (01) :86-90
[9]   Characterization of microRNA expression levels and their biological correlates in human cancer cell lines [J].
Gaur, Arti ;
Jewell, David A. ;
Liang, Yu ;
Ridzon, Dana ;
Moore, Jason H. ;
Chen, Caifu ;
Ambros, Victor R. ;
Israel, Mark A. .
CANCER RESEARCH, 2007, 67 (06) :2456-2468
[10]  
Hosoi Y, 2004, INT J ONCOL, V25, P461